CHRONIC MYELOGENOUS LEUKEMIA BCR/ABL POSITIVE COMPLICATING A PREGNANCY

被引：0
|
作者：
Tello, E. Juarez Ramirez [1 ]
Sultan, A. [1 ]
Khan, S. [2 ]
Tijani, L. [2 ]
Nugent, K. [2 ]
机构：
[1] Texas Tech Hlth Sci Ctr, Lubbock, TX USA
[2] Texas Tech Univ, Lubbock, TX 79409 USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2017年 / 65卷 / 02期
关键词：
D O I：
10.1136/jim-2016-000393.198
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
198
引用
收藏
页码：475 / 475
页数：1
相关论文
共 50 条
  • [41] Proliferating status of peripheral blood progenitor cells from patients with BCR/ABL-positive chronic myelogenous leukemia
    A Krämer
    H Löffler
    J Bergmann
    A Hochhaus
    R Hehlmann
    Leukemia, 2001, 15 : 62 - 68
  • [42] Dendritic cells as vaccine in BCR-ABL-positive chronic myelogenous leukemia -: A phase-I study.
    Westermann, J
    Kopp, J
    Körner, I
    Döhner, C
    Döhner, H
    Dörken, B
    Pezzutto, A
    BLOOD, 2001, 98 (11) : 350A - 350A
  • [43] Proliferating status of peripheral blood progenitor cells from patients with BCR/ABL-positive chronic myelogenous leukemia
    Krämer, A
    Löffler, H
    Bergmann, J
    Hochhaus, A
    Hehlmann, R
    LEUKEMIA, 2001, 15 (01) : 62 - 68
  • [44] A recombinant adenovirus encoding Bcr(64-413) induces cell death in Bcr-Abl positive chronic myelogenous leukemia cells
    Liu, J
    Wu, Y
    Estrov, Z
    Lin, SH
    Luo, W
    Talpaz, M
    Arlinghaus, RB
    BLOOD, 1997, 90 (10) : 881 - 881
  • [45] NK cells are dysfunctional in human chronic myelogenous leukemia before and on imatinib treatment and in BCR–ABL-positive mice
    C I-U Chen
    S Koschmieder
    L Kerstiens
    M Schemionek
    B Altvater
    S Pscherer
    J Gerss
    H T Maecker
    W E Berdel
    H Juergens
    P P Lee
    C Rossig
    Leukemia, 2012, 26 : 465 - 474
  • [46] NK cells are dysfunctional in human chronic myelogenous leukemia before and on imatinib treatment and in BCR-ABL-positive mice
    Chen, Ci-U
    Koschmieder, S.
    Kerstiens, L.
    Schemionek, M.
    Altvater, B.
    Pscherer, S.
    Gerss, J.
    Maecker, H. T.
    Berdel, W. E.
    Juergens, H.
    Lee, P. P.
    Rossig, C.
    LEUKEMIA, 2012, 26 (03) : 465 - 474
  • [47] Therapeutic options against BCR-ABL1 T315I-positive chronic myelogenous leukemia
    Quintas-Cardama, Alfonso
    Cortes, Jorge
    CLINICAL CANCER RESEARCH, 2008, 14 (14) : 4392 - 4399
  • [48] Differences in structural elements of Bcr-Abl oncoprotein isoforms in Chronic Myelogenous Leukemia
    Hai, Abdul
    Kizilbash, Nadeem A.
    Zaidi, Syeda Huma H.
    Alruwaili, Jamal
    Shahzad, Khuram
    BIOINFORMATION, 2014, 10 (03) : 108 - 114
  • [49] A Bcr/Abl kinase antagonist for chronic myelogenous leukemia: A promising path for progress emerges
    Sausville, EA
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (02): : 102 - 103
  • [50] Frequency of BCR-ABL Fusion Transcripts in Saudi Patients with Chronic Myelogenous Leukemia
    Elbjeirami, W. M.
    Abdulwahab, A.
    Elsayed, H.
    Elnagdi, N.
    Abd Allatif, N.
    Al-Jedani, H.
    Al Shaikh, A.
    Al-Allaf, F. A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (06): : 766 - 766
12345